Date: Thu May 12 2022 + Fri May 13 2022
Keynote: “Women’s Lives, Women’s Health Across the Lifespan”, Nancy Fugate Woods, PhD, RN, FAAN (Dean & Professor Emerita, Univ. of Washington School of Nursing; Co-Director, de Tornyay Center for Healthy Aging)
Video: Video from this event will be available soon.
Sponsored by: Center for Midlife Science
“Per- and Polyfluoroalkyl Substances (PFAS) and Women’s Reproductive Health: Findings from The Study of Women’s Health Across the Nation” with Center Postdoctoral Research Fellow Ning Ding, PhD, MPH (School of Public Health, University of Michigan)
Sponsored by: Michigan Center on Lifestage Environmental Exposures and Disease (M-LEEaD) Integrated Health Sciences Core
“Structural Racism and Midlife Health” is a webinar series featuring papers in an upcoming special thematic issue on Racism and Midlife Health sponsored by Women’s Midlife Health, a BioMedCentral open-access journal, in collaboration with the Center for Midlife Science at the University of Michigan, and the Massachusetts General Hospital Department of Medicine Diversity and Inclusion Board. Published manuscripts are available at https://womensmidlifehealthjournal.biomedcentral.com.
Watch the first in our “Structural Racism and Midlife Health” series: “This Is Our Lane: Talking with Patients About Racism” with Michelle S. Diop, MD, ScM, Department of Medicine, Massachusetts General Hospital & Harvard Medical School; and Sascha N. Murillo MD, Department of Medicine, Massachusetts General Hospital & Harvard Medical School; and “Structural Racism and the Impact on Incarcerated Midlife Women” with Juana Hutchinson-Colas, MD, Rutgers Robert Wood Johnson Medical School.
Moderators: Sherri-Ann M. Burnett-Bowie, MD, MPH, Department of Medicine, Massachusetts General Hospital & Harvard Medical School; and Gloria Bachmann, MD, Rutgers Robert Wood Johnson Medical School
“Structural Racism and Midlife Health” is a webinar series featuring papers in an upcoming special thematic issue on Racism and Midlife Health sponsored by Women’s Midlife Health, a BioMedCentral open-access journal, in collaboration with the Center for Midlife Science at the University of Michigan, and the Massachusetts General Hospital Department of Medicine Diversity and Inclusion Board. Published manuscripts are available at https://womensmidlifehealthjournal.biomedcentral.com.
Watch the second in our “Structural Racism and Midlife Health” series: “Disparities in Reproductive Aging and Midlife Health between Black and White women: Study of Women’s Health Across the Nation (SWAN)” with Tené T. Lewis, PhD, Department of Epidemiology, Emory University; and Siobán D. Harlow, PhD, Department of Epidemiology, University of Michigan; and “Taking Action to Advance the Study of Race and Ethnicity: The Women’s Health Initiative (WHI)” with Shawna Follis, PhD, MS, Department of Medicine, Stanford University School of Medicine; Monik C. Jiménez, ScD, SM, FAHA, Harvard Medical School and T.H. Chan School of Public Health; and Lorena Garcia, MPH, DrPH, Division of Epidemiology, Department of Public Health Sciences, UC Davis School of Medicine.
Moderators: Sherri-Ann M. Burnett-Bowie, MD, MPH, Department of Medicine, Massachusetts General Hospital & Harvard Medical School; and Gloria Bachmann, MD, Rutgers Robert Wood Johnson Medical School
Midlife: the period of life between 40 — 64 years of age
The Center for Midlife Science specializes in the study of multifaceted diseases and health conditions, including osteoarthritis, diabetes, osteoporosis, sensory and physical function impairment, particularly their initiation and progression during the midlife. Our faculty and affiliates work to understand the course of development of these conditions, as well as the factors that contribute to variations in the course of development, such as genetics, environment and aging. The Center houses two 20-year cohort studies, the Study of Women’s Health Across the Nation (SWAN) and the Michigan Bone Health and Metabolism Study (descended from the Tecumseh Community Health Study). Learn more about the Center.
This special lecture honors Dr. Sower’s extraordinary scientific contributions to the field of women’s health and to inspire young scholars to transcend the boundaries between varying fields of research to advance women’s health. Dr. Sower’s unique insights into the breadth and depth of underlying physiological processes common to multiple diseases as well as her efforts to understand the linkages between ovarian and chronological aging has contributed substantially to the advancement of science. As a result of her contributions, women’s health grew from a peripheral field of study to a major discipline and we honor her legacy by inviting a groundbreaking researcher to present a lecture in her name. Learn more about the lecture.
Initiated in 2013, MiLES is a newly established cohort study which creates and maintains the MiLES Longitudinal Cohort & Biobank, including lupus cases from the southeast Michigan surveillance registry as well as population-based controls.
The 32-year MBHMS follows the daughters of participants in the historic Tecumseh Community Health Study to evaluate the impact of aging-related processes including menopause and the secular increase in obesity on the development and progression of musculoskeletal disease and declines in physical functioning. This study addresses a significant gap in scientific knowledge that impedes our ability to optimize fracture prevention strategies. If our hypotheses prove correct, baseline external bone size may be used as an additional parameter to identify women most likely to lose bone strength rapidly during the MT and who might benefit from early intervention.
SWAN Genomic Analyses performed dense genome-wide genotyping and imputation of genetic variants throughout the genome to the Haplotype Reference Consortium (HRC) reference panel in 1538 SWAN participants. This project enables SWAN to participate in genetic consortia focused on reproductive aging as well as risk factors for health and disease in women with data uploaded to dbGaP. We are also conducting gene-based analyses to assess the association of menopausal traits, including vasomotor symptoms, with genetic loci previously identified to be associated with age at menarche and menopause. (AG 017719)
